Gen2 Neuroscience Company

Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.

Founded Date: 2016
Last Funding Type: Seed
Headquarters: Manchester, Manchester, United Kingdom
Investors Number: 1
Employee Number: 1-10
Industry: NeuroTech
Last Funding Date: 06-03-2016
Funding Status: Seed